Health

Patients with atrial fibrillation (Afib) and stable coronary artery disease (CAD) have seen positive results with edoxaban (Savaysa) monotherapy, according to the EPIC-CAD trial. The study revealed that a 12-month composite of death, myocardial infarction, stroke, embolism, urgent revascularization, or bleeding events occurred less frequently in patients on edoxaban monotherapy compared to those on dual
0 Comments
A recent randomized clinical trial conducted by Dr. Benjamin O’Brien, MD, PhD, at Charité Universitätsmedizin Berlin, has shed light on the ineffectiveness of keeping potassium levels high after cardiac surgery in preventing post-surgical atrial fibrillation (Afib). Contrary to common practice, the study found that there was no significant difference in the occurrence of new-onset Afib
0 Comments
A recent cohort study found that first-line antidepressants may have a protective effect against falls and related injuries in older adults. The study, which included over 100,000 Medicare beneficiaries with newly diagnosed depression, showed that the use of certain antidepressants was associated with a decreased risk of falls compared to no treatment. This has significant
0 Comments
In the medical field, professionals constantly face a wide array of challenges and considerations when treating patients. From the risk of pterygium in non-surfers to the use of prophylactic antibiotics for Olympians, the range of topics discussed by experts such as Matthew Gorski and Jonathan Finnoff highlights the diverse perspectives within the medical community. It
0 Comments